1. Home
  2. APLS vs ASTS Comparison

APLS vs ASTS Comparison

Compare APLS & ASTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLS
  • ASTS
  • Stock Information
  • Founded
  • APLS 2009
  • ASTS 2019
  • Country
  • APLS United States
  • ASTS United States
  • Employees
  • APLS N/A
  • ASTS N/A
  • Industry
  • APLS Biotechnology: Pharmaceutical Preparations
  • ASTS Telecommunications Equipment
  • Sector
  • APLS Health Care
  • ASTS Consumer Discretionary
  • Exchange
  • APLS Nasdaq
  • ASTS Nasdaq
  • Market Cap
  • APLS 3.6B
  • ASTS 4.1B
  • IPO Year
  • APLS 2017
  • ASTS N/A
  • Fundamental
  • Price
  • APLS $27.52
  • ASTS $28.64
  • Analyst Decision
  • APLS Buy
  • ASTS Strong Buy
  • Analyst Count
  • APLS 18
  • ASTS 5
  • Target Price
  • APLS $46.71
  • ASTS $40.04
  • AVG Volume (30 Days)
  • APLS 1.4M
  • ASTS 14.2M
  • Earning Date
  • APLS 02-28-2025
  • ASTS 03-03-2025
  • Dividend Yield
  • APLS N/A
  • ASTS N/A
  • EPS Growth
  • APLS N/A
  • ASTS N/A
  • EPS
  • APLS N/A
  • ASTS N/A
  • Revenue
  • APLS $715,216,000.00
  • ASTS $2,500,000.00
  • Revenue This Year
  • APLS $97.25
  • ASTS N/A
  • Revenue Next Year
  • APLS $12.68
  • ASTS $4,467.90
  • P/E Ratio
  • APLS N/A
  • ASTS N/A
  • Revenue Growth
  • APLS 162.10
  • ASTS N/A
  • 52 Week Low
  • APLS $24.34
  • ASTS $1.97
  • 52 Week High
  • APLS $71.90
  • ASTS $39.08
  • Technical
  • Relative Strength Index (RSI)
  • APLS 38.99
  • ASTS 56.14
  • Support Level
  • APLS $26.84
  • ASTS $27.05
  • Resistance Level
  • APLS $28.59
  • ASTS $33.55
  • Average True Range (ATR)
  • APLS 1.12
  • ASTS 2.88
  • MACD
  • APLS -0.03
  • ASTS 0.49
  • Stochastic Oscillator
  • APLS 18.09
  • ASTS 66.58

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

About ASTS AST SpaceMobile Inc.

AST SpaceMobile Inc is a satellite designer and manufacturer. The company is building a cellular broadband network in space to operate directly with standard, unmodified mobile devices, and off-the-shelf mobile phones based on extensive IP and patent portfolio. It has focused on eliminating the connectivity gaps faced by mobile subscribers and finally bringing broadband to the billions who remain unconnected. The Company's spaceMobile Service is being designed to provide cost-effective, high-speed Cellular Broadband services to end-users who are out of terrestrial cellular coverage using existing mobile devices.

Share on Social Networks: